New Insights Into Morphometry Studies 2017
DOI: 10.5772/intechopen.69098
|View full text |Cite
|
Sign up to set email alerts
|

MRI Morphometry of the Brain and Neurological Diseases

Abstract: The diagnosis of diseases of the brain is based on additional methods, conirming the clinical diagnosis. One of the most objective methods is magnetic resonance imaging (MRI). A detailed quantitative evaluation became possible after the introduction of MRI voxel-morphometry-statistical analysis of structural MRI images using a computerized segmentation mater of the brain gray and white mater. The decrease in the volume of the brain, as a manifestation of cerebral atrophy, is a common feature of many neurologic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Image intensity measures include intensity properties of T1w, T2w, and T1w and T2w cortical contrast. The alterations in morphometry and intensity indicate the abnormal development and changed composition of brain tissue (Kotov, 2017;Bloem et al, 2018), which are common features of many neurological diseases. Cortical contrast has also been confirmed to serve as a sensitive cortical marker of brain development and psychopathology (Lewis et al, 2018;Norbom et al, 2019).…”
Section: Imaging Measuresmentioning
confidence: 99%
“…Image intensity measures include intensity properties of T1w, T2w, and T1w and T2w cortical contrast. The alterations in morphometry and intensity indicate the abnormal development and changed composition of brain tissue (Kotov, 2017;Bloem et al, 2018), which are common features of many neurological diseases. Cortical contrast has also been confirmed to serve as a sensitive cortical marker of brain development and psychopathology (Lewis et al, 2018;Norbom et al, 2019).…”
Section: Imaging Measuresmentioning
confidence: 99%
“…Generally, the decrease in brain volume as a result of cerebral atrophy is one of the common characteristics associated with structural abnormalities of brain for many neurological disorders. As an example, patients diagnosed with Parkinson’s disease show a slight decrease in substantia nigra in comparison with normal control subjects [ 2 ]. However, the degeneration of neurons of substantia nigra is significantly higher in patients with chronic Parkinson’s disease in comparison to the early stage of the disease.…”
Section: Introductionmentioning
confidence: 99%